Evidence map›Paper›PMID 35445373›Full record

ArticleMolecular and cellular biochemistry2022

Establishment and application of a human osteosarcoma U-2OS cell line that can stably express Cas9 protein.

Yonghua Zhou, Yingjie Li, Yu Zhang, Zilin Yi, Minggui Jiang

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yonghua ZhouDepartment of Biological and Environmental Engineering, Changsha University, Changsha, 410022, China. ZYH717909@163.com.ORCID http://orcid.org/0000-0002-6205-2936
Yingjie LiDepartment of Biological and Environmental Engineering, Changsha University, Changsha, 410022, China.
Yu ZhangDepartment of Biological and Environmental Engineering, Changsha University, Changsha, 410022, China.
Zilin YiDepartment of Biological and Environmental Engineering, Changsha University, Changsha, 410022, China.
Minggui JiangHunan Fenghui Biotechnology Co. Ltd, Changsha, 410000, China.
Changsha University · CN

Funding

Scientific Research Foundation of Hunan Provincial Education Department 20B058The Talent Introduction Project of Changsha University SF1815
6 · The paper itself

Abstract

Osteosarcoma is the most common primary malignant bone tumor, and U-2OS is a common osteosarcoma cell model. The study obtained a human osteosarcoma U-2OS tool cell line which could stably express Cas9 protein, and we reported its production method and application. Firstly, we introduced a Cas9 protein expression gene and an antibiotic screening marker gene through CRISPR/Cas9 system to construct a human osteosarcoma U-2OS tool cell line which could stably express Cas9 protein. Secondly, as the cell line could stably express Cas9 protein, it was only transfected alone a small sgRNA fragment for related gene editing, we then transfected, respectively, a small ETV4 and MALAT1 sgRNA fragment to U-2OS tool cell line for gene editing. Lastly, the Q-PCR results showed that the transcription levels of ETV4 and MALAT1 were significantly decreased, and western blotting result showed that the translation level of ETV4 was significantly decreased, these results indicated that the constructed U-2OS tool cell line could effectively edit protein-coding gene (ETV4) and long non-coding RNA gene (MALAT1). The results of this study also indicated that the constructed U-2OS tool cell line could greatly improve the efficiency of gene editing. Therefore, the genetic engineering cell line provided by the study is of great significance for studying the pathogenesis and regulatory network of osteosarcoma, and for preventing and treating bone tumor as soon as possible.

Indexed as

Bone NeoplasmsOsteosarcomaRNA, Long NoncodingCell Line, TumorCRISPR-Associated Protein 9HumansCRISPR-Associated Protein 9RNA, Long NoncodingApplicationCas9 proteinHuman osteosarcoma U-2OS

Identifiers

PMID35445373
OpenAlexW4224257633

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.